Recent Articles
Can probiotics help calm inflammatory bowel disease?
Could imaging scans replace biopsies during prostate cancer screening?
Celiac disease: Exploring four myths
Does drinking water before meals really help you lose weight?
Which migraine medications are most helpful?
Want a calmer brain? Try this
Do tattoos cause lymphoma?
PTSD: How is treatment changing?
Concussion in children: What to know and do
Ever hear of tonsil stones?
Prostate Knowledge Archive
Articles
Newer drugs are improving survival for men with metastatic prostate cancer
Men with prostate cancer that has spread outside the gland now have several newer drug options available for treatment, and research has found that taking any of them is likely to improve survival duration.
New study downplays potential risk of dementia and Alzheimer’s disease among elderly men treated with hormonal therapy for prostate cancer
The male hormone testosterone contributes to normal brain function, and some research links memory loss in older men to testosterone declines that occur naturally with aging. However, testosterone is also like jet fuel for prostate tumors, causing them to grow faster, so during cancer treatment doctors will often give hormonal therapies that suppress its activities […]
Study investigates treatment regret among prostate cancer survivors
Charles Schmidt As they get older, do men with prostate cancer come to regret the treatment decisions they made? A new study of men diagnosed during the mid-1990s indicates that some of them will. Richard Hoffman, a professor of internal medicine and epidemiology at the University of Iowa Carver College of Medicine in Iowa City, […]
New study supports lifesaving benefits from PSA screening
Charles Schmidt Does screening for prostate cancer with the prostate-specific antigen (PSA) test save lives? A new study suggests that it does, but at the risk of exposing men with slow-growing tumors that may not be life-threatening to treatments they may not really need. Published in Annals of Internal Medicine, the study reconciles conflicting results […]
Combination hormonal therapy boosts survival in men with aggressive prostate cancer
Charlie Schmidt A standard approach for treating aggressive prostate cancer is to give therapies that block testosterone, a tumor-stimulating hormone. Should initial hormonal therapies fail, doctors can switch to other drugs that suppress testosterone in different ways. One of them, a drug called abiraterone, has been shown to significantly extend lifespans in men who have […]
Influential task force revises its position on PSA screening tests
Charlie Schmidt In 2012, the US Preventive Services Task Force (USPSTF) took the unprecedented step of recommending against prostate cancer screening for all men, regardless of age, race, or family history. Now this influential group of independent experts is reassessing its position based on more recent data. Instead of discouraging screening altogether, the UPSTF is […]
New study recommends immediate radiation when PSA Levels spike after prostate cancer surgery
Following surgery to remove a cancerous prostate gland, some men experience a biochemical recurrence, meaning that prostate-specific antigen (PSA) has become detectable in their blood. Since only the prostate releases PSA, removing the gland should drop this protein to undetectable levels in the body. Detecting PSA could signify that prostate cancer cells are lingering, and […]
Treatment versus monitoring of prostate cancer: Survival rates the same after 10 years
Charles Schmidt A pair of new studies provides useful information to men facing challenging decisions about what to do after being diagnosed with early prostate cancer. Researchers tracked men for 10 years and found that virtually none died of the illness, even if they decided against treating it. Early prostate tumors confined to the prostate […]
New urine test predicts high-grade cancer
Suspicious findings from prostate cancer screening are often followed by a procedure most men would prefer to avoid: a prostate biopsy. But what if biopsies actually could be avoided on the basis of non-invasive test results? Screening tests are moving in that direction, with some intriguing results. One of them, the Prostate Health Index blood test, combines measures of three forms of prostate-specific antigen (PSA) into a score that helps doctors predict if a cancer is likely to progress, with an aim to circumvent biopsies that aren’t necessary.
Risks of active surveillance for men with intermediate-risk prostate cancers
Men diagnosed with slow-growing prostate tumors that likely won’t be harmful during their lifetimes can often avoid immediate treatment. Instead, they can have their tumor monitored using a strategy called active surveillance. With this approach, doctors perform periodic checks for tumor progression and start treatment only if the cancer begins to metastasize, or spread. Active […]
Recent Articles
Can probiotics help calm inflammatory bowel disease?
Could imaging scans replace biopsies during prostate cancer screening?
Celiac disease: Exploring four myths
Does drinking water before meals really help you lose weight?
Which migraine medications are most helpful?
Want a calmer brain? Try this
Do tattoos cause lymphoma?
PTSD: How is treatment changing?
Concussion in children: What to know and do
Ever hear of tonsil stones?
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!
Sign Up